farnesol has been researched along with Staphylococcal Infections in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Banin, E; Catelani, T; Fiandra, L; Ivanova, A; Ivanova, K; Jacobi, G; Mantecca, P; Natan, M; Tzanov, T | 1 |
Bhattacharyya, S; Briggs, T; Ducheyne, P; Knabe, C; Qu, H; Sheth, N; Woelfle, UC | 1 |
Bruno, V; Ibrahim, A; Jabra-Rizk, MA; Kong, EF; McCracken, C; Piepenbrink, K; Shetty, AC; Vila, T | 1 |
Azeredo, J; Cerca, N; Gomes, F; Leite, B; Oliveira, R; Teixeira, P | 1 |
Akiyama, H; Huh, WK; Ichikawa, H; Iwatsuki, K; Katsuyama, M; Ogawa, S; Oono, T; Yamasaki, O | 1 |
5 other study(ies) available for farnesol and Staphylococcal Infections
Article | Year |
---|---|
Antibacterial, Antibiofilm, and Antiviral Farnesol-Containing Nanoparticles Prevent
Topics: Anti-Bacterial Agents; Antiviral Agents; Biofilms; COVID-19; Drug Resistance, Multiple; Farnesol; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanoparticles; SARS-CoV-2; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Dual local drug delivery of vancomycin and farnesol for mitigation of MRSA infection in vivo - a pilot study.
Topics: Animals; Bone and Bones; Coated Materials, Biocompatible; Drug Delivery Systems; Farnesol; Male; Methicillin-Resistant Staphylococcus aureus; Pilot Projects; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin; X-Ray Microtomography | 2020 |
Topics: Biofilms; Candida albicans; Farnesol; Microbial Interactions; Oxidative Stress; Quorum Sensing; Staphylococcal Infections; Staphylococcus aureus; Virulence; Virulence Factors; Xanthophylls | 2019 |
Farnesol as antibiotics adjuvant in Staphylococcus epidermidis control in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Farnesol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Microbial Viability; Plankton; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Stem Cells; Tetracycline; Time Factors; Vancomycin | 2011 |
Actions of farnesol and xylitol against Staphylococcus aureus.
Topics: Dermatitis, Atopic; Farnesol; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Xylitol | 2002 |